4//SEC Filing
Cunliffe Sean 4
Accession 0001096481-11-000009
CIK 0001096481other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:34 PM ET
Size
9.3 KB
Accession
0001096481-11-000009
Insider Transaction Report
Form 4
Cunliffe Sean
SVP, Sales & Marketing
Transactions
- Other
Common Stock
2009-09-08−70,700→ 70,700 total - Other
Stock Option w/Tandem SAR
2009-11-11−100,000→ 0 totalExercise: $1.28From: 2009-12-01Exp: 2014-11-10→ Common Stock (100,000 underlying) - Other
Stock Option w/Tandem SAR
2010-03-08−85,000→ 100,000 totalExercise: $1.05From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
- [F2]Purchase price was not provided on Form 3 filing.
Documents
Issuer
ANGIOTECH PHARMACEUTICALS INC
CIK 0001096481
Entity typeother
Related Parties
1- filerCIK 0001472229
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 6:34 PM ET
- Size
- 9.3 KB